Session InformationLymphodepletion chemotherapy followed by infusion of T cells that are genetically modified to express a chimeric antigen receptor (CAR) targeted to CD19 is a novel therapy for patients with relapsed and/or refractory B cell malignancies. In this seminar factors associated with outcomes of CAR-T cell therapy in adult B cell malignancies will be discussed … Read more
Session InformationThe INOVATe Study (Individualised Ovarian Cancer Treatment Through Integration of Genomic Pathology into Multidisciplinary Care), is a major precision oncology program that has enrolled over 750 women in NSW since 2016. The goal is to facilitate recruitment to Phase I/II clinical trials of targeted cancer treatments through multi-modal molecular testing. In this Molecular Tumour … Read more
In collaboration with Sydney Health Partners and NSW Regional Health Partners, the Maridulu Budyari Gumal (SPHERE) Cancer CAG presents the October Molecular Tumour Board in our NSW Cancer Research statewide seminar series: Clinical Aspects in Adult Solid Cancers. A Molecular Tumour Board (MTB) is a multi-disciplinary forum for discussion, interpretation and communication about molecular results that may have implications for patient care. MTBs often include geneticists, bioinformaticians and molecular biologists … Read more
The concept of Precision Oncology is to optimise management for individual cancer patients based on molecular features of their disease. A Molecular Tumour Board (MTB) is a multi-disciplinary forum for discussion, interpretation and communication about molecular results that may have implications for patient care. MTBs often include geneticists, bioinformaticians and molecular biologists in addition to … Read more
